Stay updated on Dupilumab in Chronic Urticaria Clinical Trial

Sign up to get notified when there's something new on the Dupilumab in Chronic Urticaria Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dupilumab in Chronic Urticaria Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2 on the page. This appears to be a minor maintenance update that does not affect study data or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:06:28.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.1. This update relates to page version metadata and does not modify study details, eligibility criteria, or outcomes.
    Difference
    0.1%
    Check dated 2025-11-24T14:31:26.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Notice about lapse in government funding and related operating status information was removed from the page.
    Difference
    0.4%
    Check dated 2025-11-17T06:39:01.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Minor layout and formatting changes observed on the Study Details page, with no changes to core study data (status, enrollment, endpoints, eligibility). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T01:11:59.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Added a government funding status notice and updated the version to v3.2.0; removed the previous version tag v3.1.0.
    Difference
    4%
    Check dated 2025-10-05T10:08:49.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    Added version tag v3.1.0 and removed several drug-safety topic sections; indicates content pruning in the drug-safety area with a version upgrade.
    Difference
    0.4%
    Check dated 2025-09-28T03:12:35.000Z thumbnail image

Stay in the know with updates to Dupilumab in Chronic Urticaria Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dupilumab in Chronic Urticaria Clinical Trial page.